Profil bibliographique

Claudia Schumacher

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

183Publications signalées

3665Citations signalées

4Affiliations récentes

Institutions déclarées

Gemeinsamer Bundesausschuss St. Elisabeth-Hospital Bochum St. Elisabethen-Krankenhaus Frankfurt University Hospital Cologne

Domaines associés

Breast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchAdvanced Breast Cancer TherapiesLung Cancer Treatments and MutationsCancer Treatment and Pharmacology

Publications récentes

Accès ouvert 2025 supplementary-materialsOpenAlex

"Supplementary Table S6 from Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial

Monika Graeser, Oleg Gluz, Claudia Biehl, Daniel Ulbrich-Gebauer et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Figure S1 from Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial

Monika Graeser, Oleg Gluz, Claudia Biehl, Daniel Ulbrich-Gebauer et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Figure S3 from Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial

Monika Graeser, Oleg Gluz, Claudia Biehl, Daniel Ulbrich-Gebauer et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Table S3 from Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial

Monika Graeser, Oleg Gluz, Claudia Biehl, Daniel Ulbrich-Gebauer et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

"Supplementary Table S5 from Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial

Monika Graeser, Oleg Gluz, Claudia Biehl, Daniel Ulbrich-Gebauer et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Table S1 from Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial

Monika Graeser, Oleg Gluz, Claudia Biehl, Daniel Ulbrich-Gebauer et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Table S2 from Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial

Monika Graeser, Oleg Gluz, Claudia Biehl, Daniel Ulbrich-Gebauer et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Figure S2 from Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial

Monika Graeser, Oleg Gluz, Claudia Biehl, Daniel Ulbrich-Gebauer et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Table S4 from Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial

Monika Graeser, Oleg Gluz, Claudia Biehl, Daniel Ulbrich-Gebauer et autres

0 citations

2025 articleOpenAlex

Leitlinie „Insomnie bei Erwachsenen“ – Update 2025 (AWMF-Registernummer 063-003)

K. Spiegelhalder, Erika Baum, Matthias Becker, C. Cornaro et autres

6 citationsSomnologie - Schlafforschung und Schlafmedizin

Accès ouvert 2025 articleOpenAlex

Prediction of survival after de-escalated neoadjuvant therapy in HER2-positive early breast cancer: a pooled analysis of three WSG trials

M Graeser, Oleg Gluz, Christine zu Eulenburg, Sherko Küemmel et autres

6 citationsAnnals of Oncology

Accès ouvert 2025 conference-abstractOpenAlex

Patient outcomes in WSG-ADAPT according to NATALEE and MonarchE risk criteria.

Oleg Gluz, Michael Wilhelm Braun, Sherko Kuemmel, Ulrike Nitz et autres

1 citationJournal of Clinical Oncology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.